Legend Biotech Corp - ADR has a share price target of US$ 78, revenue growth forecast of 63.3%, and profit growth estimate of 17.1% for FY25, based on top 23 analyst calls.
Upgrade Your Plan
You need to upgrade your subscription plan to access this feature